 The ARK Genomic Revolution ETF ARKG, 2.01 started a position in Burning Rock Biotech BNR, 10.69 , a Chinese cancer sequencing technology company that jumped 11 after reporting third-quarter results. The loss-making biotech saw its revenue edge up 2 in the third quarter and is planning two products for early-stage cancer patients next year. 